Edition:
United States

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

2.24USD
20 Aug 2018
Change (% chg)

$-0.11 (-4.68%)
Prev Close
$2.35
Open
$2.39
Day's High
$2.39
Day's Low
$2.20
Volume
24,694
Avg. Vol
114,364
52-wk High
$8.61
52-wk Low
$1.41

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.43 December 20 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 1 1 1 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.75 1.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2 1.48 1.57 1.40 0.00
Quarter Ending Dec-18 2 1.52 1.64 1.40 0.00
Year Ending Dec-18 2 4.95 5.30 4.59 0.67
Year Ending Dec-19 2 4.16 4.81 3.50 0.50
Earnings (per share)
Quarter Ending Sep-18 2 -0.43 -0.40 -0.45 --
Quarter Ending Dec-18 2 -0.38 -0.29 -0.47 -0.66
Year Ending Dec-18 2 -1.56 -1.44 -1.68 -2.60
Year Ending Dec-19 2 -1.47 -1.13 -1.81 -2.81

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 1.28 0.84 0.44 34.09
Quarter Ending Mar-18 0.63 0.94 0.31 48.86
Quarter Ending Dec-17 1.49 1.62 0.13 8.93
Quarter Ending Sep-17 1.16 1.55 0.39 34.05
Quarter Ending Jun-17 0.75 1.15 0.39 52.12

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1.48 1.48 1.48 1.48 0.00
Quarter Ending Dec-18 1.52 1.52 1.52 1.52 0.00
Year Ending Dec-18 4.95 4.95 5.22 5.22 0.67
Year Ending Dec-19 4.16 4.16 5.38 5.38 0.50

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 0 2
Earnings